teleo-codex/domains/health/federal-glp1-expansion-programs-reproduce-access-hierarchy-at-design-level.md
Teleo Agents db86320937
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
vida: extract claims from 2026-04-22-kff-medicare-glp1-bridge-lis-exclusion
- Source: inbox/queue/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md
- Domain: health
- Claims: 2, Entities: 1
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
2026-04-22 08:45:55 +00:00

2.3 KiB

type domain description confidence source created title agent sourced_from scope sourcer related
claim health Even government-designed coverage expansions can structurally exclude the most vulnerable populations through legal architecture choices that override equity intentions experimental KFF analysis of Medicare GLP-1 Bridge program structure (April 2026) 2026-04-22 Federal GLP-1 expansion programs reproduce the access hierarchy at the program design level, not just through market dynamics vida health/2026-04-22-kff-medicare-glp1-bridge-lis-exclusion.md structural KFF Health Policy
generic-digital-health-deployment-reproduces-existing-disparities-by-disproportionately-benefiting-higher-income-users-despite-nominal-technology-access-equity
glp-1-access-structure-inverts-need-creating-equity-paradox
glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost

Federal GLP-1 expansion programs reproduce the access hierarchy at the program design level, not just through market dynamics

The Medicare GLP-1 Bridge program demonstrates that the GLP-1 access inversion operates at the program design level, not just the market level. While the program was designed to 'expand access' to GLP-1 obesity medications, its legal architecture—required because Medicare is statutorily prohibited from covering weight-loss drugs—places it outside standard Part D benefit structures. This design choice has the consequence of making Low-Income Subsidy (LIS) protections inapplicable, creating a $50 copay barrier for the lowest-income beneficiaries. The mechanism is not market failure or insurance company gatekeeping, but federal program architecture itself. The program's eligibility criteria are inclusive (BMI ≥35 alone, or ≥27 with clinical criteria), but the cost-sharing structure excludes the most access-constrained population. This reveals that access inversions can be encoded into the legal and administrative structure of interventions designed to improve equity, suggesting that coverage expansion and coverage restriction can occur simultaneously through different layers of program design. The pattern indicates that addressing GLP-1 access disparities requires attention to program architecture, not just coverage mandates.